Laninamivir Octanoate (CAS 203120-46-1)

Laninamivir octanoate is a chemical derivative of laninamivir, itself a neuraminidase inhibitor. This compound is characterized by the esterification of laninamivir with octanoic acid, which alters its solubility and pharmacokinetic properties. In scientific research, laninamivir octanoate is primarily used to study the inhibition of neuraminidase, an enzyme critical for the release of newly formed virus particles from infected cells. The primary mechanism of action of laninamivir octanoate involves the selective and irreversible inhibition of viral neuraminidase. By binding to the active site of this enzyme, laninamivir octanoate prevents the cleavage of sialic acid residues from glycoproteins and glycolipids on the surface of host cells. This blockage is crucial because it stops the spread of the virus to adjacent cells, effectively containing the viral infection within a limited area. In virology research, laninamivir octanoate is used to understand the dynamics of viral infections and the role of neuraminidase in the life cycle of influenza viruses. Studies involving this compound help in elucidating how influenza viruses evolve to escape immune detection and develop resistance to antiviral agents. Additionally, laninamivir octanoate is used in studies focusing on the development of enhanced delivery systems for antiviral agents. Due to its modified solubility and stability properties, researchers investigate how such changes affect the distribution and efficacy of the compound within biological systems.